A new engineered gene-editing system, proven in bacteria and showing promise for use in plants, animals and humans, addresses ...

CRISPR is one of this generation’s most profound innovations, with the potential to fundamentally alter the realm of modern ...

The limits of Anthropic’s finding also point to a more fundamental issue. What made Crispr revolutionary was that scientists ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 5.82% at $54.00. The stock trailed the S&P 500, which registered a daily gain of 0.58%. Meanwhile, the Dow experienced a rise of ...

The company had fallen out of investor favor; its recovery was impressive.

CRISPR halves model-generation time and cuts costs by ~40%, while automation, aquatic models, genetic testing and cryobanking boost efficiency and client retention.Dublin, Oct. 07, 2026 (GLOBE ...

Researchers used CRISPR to remove CD33 from donor stem cells, potentially giving doctors a way to attack aggressive blood ...

Gene-editing techniques could soon allow researchers to replace entire genes and engineer complex cellular circuits — if the ...

Anthropic announced today that its Claude artificial intelligence (AI) system identified a previously unknown biological ...

Don't read too much into this year's lackluster performance. Near-term catalysts are firming up.

Anthropic’s AI-driven discovery of a new CRISPR-like enzyme system has pressured gene-editing stocks, but the technology ...

The detection effort enlisted roughly 950 AI agents that spent more than 21 hours combing through DNA sequence databases.